The blog will be on hold for a few days over the holidays. But first, here is my list of the top ten stories in health, health care, medicine and science over this past year.
1. Conflicts of interest in health care, medicine, research (just one example: the recent news from the Cleveland Clinic)
2. Avian flu (including hype of unproven Tamiflu)
3. Medicareâs prescription drug benefit â“ âgreatest advance for seniors in 40 yearsâ? or âa boondoggleâ??
4. Medicaid cuts â“ impact on states
5. Fallout from aggressive marketing of Cox-2 inhibitors
6. Science stifled by Bush administration
7. Drug prices continue to outpace inflation
8. Continued cost-shifting to employees (AKA consumer-driven health plans)
9. Whatâs going on at the FDA?
10. Lots of news about two people â“ Terri Schiavo and Peter Jennings â“ but relatively little news about 45-million Americand who are uninsured and perhaps twice that number who are under-insured.
A year from now, it would be terrific if the contents of this list would be markedly different.
Opinions on other issues in news, journals, PR, advertising, marketing
Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro
Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.
Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like